|
Volume 272, Number 42,
Issue of October 17, 1997
pp. 26742-26748
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
African Trypanosomes Have Differentially Expressed Genes Encoding
Homologues of the Leishmania GP63 Surface Protease*
(Received for publication, April 11, 1997, and in revised form, July 3, 1997)
Najib M. A.
El-Sayed
and
John E.
Donelson
From the Department of Biochemistry, University of Iowa,
Iowa City, Iowa 52242
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
The genomes of various Leishmania
parasites contain tandemly arrayed genes encoding an abundant 63-kDa
surface glycoprotein called GP63. Leishmania GP63s are
metalloproteases that play an important role in the invasion and
survival of the parasites within the macrophage, and their presence on
the Leishmania surface has been correlated with resistance
to complement-mediated lysis. Here we report the identification of
GP63-like genes in African trypanosomes. The predicted trypanosome and
Leishmania GP63s share a metalloprotease catalytic site
motif of HEXXH as well as 19 cysteines and 10 prolines,
implying a conservation of enzymatic activity and secondary/tertiary
structure. The trypanosome GP63 genes are transcribed equally in
procyclic and bloodstream trypanosomes, but their mRNAs accumulate
to a 50-fold higher steady state level in bloodstream trypanosomes,
where the ratio of mRNAs for GP63 and variant surface glycoprotein
is about 1:150. Transcription of the GP63 genes is sensitive to
-amanitin, indicating that they are transcribed by a different
polymerase than the variant surface glycoprotein genes. These results
lead to a reconsideration of the potential functions of GP63, inasmuch
as African trypanosomes are not known to interact with macrophages and
do not have an intracellular stage during their life cycle.
INTRODUCTION
During its life cycle, the trypanosomatid protozoan parasite
Leishmania exists as an extracellular form, the
promastigote, in its sandfly vector and as an intracellular form, the
amastigote, in macrophages of its mammalian host (1). Promastigotes of all Leishmania species examined to date possess on their
surface an abundant 63-kDa glycoprotein, called
GP631 or leishmanolysin, that
is a zinc-metalloproteinase with a broad substrate specificity and pH
optimum (2-4). Leishmania GP63s and their genes have been
the subject of extensive investigation and many reviews (5-8). These
studies have included determinations of the structure and
post-translational modifications of the protein, characterizations of
its protease activity, and elucidations of the chromosomal organization
and differential expression of the multicopy GP63 genes. Nascent GP63s
have an N-terminal prepropeptide that must be removed for activation of
the protease activity and most nascent GP63s have a C-terminal
hydrophobic tail that is replaced by a glycosylphosphatidylinositol
(GPI) anchor (9). Depending on the Leishmania species,
infective (metacyclic) promastigotes can have as many as 500,000 GP63
molecules on their surface (7, 8).
A number of different functions have been ascribed to
Leishmania GP63s, several of which implicate GP63 in the
interaction between the infective promastigote and the macrophage. GP63
has been reported to participate in the entry of promastigotes into macrophages (10-14) and to contribute to the survival of amastigotes in the phagolysosome of the macrophage (15, 16). The presence of
proteolytically active GP63 on the surface of promastigotes has also
been correlated with resistance of the parasite to complement-mediated lysis (17, 18). In addition, recombinant versions of GP63 have been
found to be partially protective against challenge by infective
Leishmania (19-23).
A homologue of Leishmania GP63 has been reported in another
trypanosomatid, Crithidia fasciculata (24). C. fasciculata is not known to infect a mammalian host. Its life
cycle appears to be confined to mosquitoes, and it is thought to have
two predominant developmental forms, one adhering to the lining of the
insect's midgut and the other existing within the lumen of the gut (7, 25). A biological role for the C. fasciculata GP63 remains
obscure. It might protect the organism from the immune response of the insect, it might be an evolutionary vestige of an era when C. fasciculata had another host, or it may have a function yet to be
discovered.
African trypanosomes are a third group of protozoan parasites that,
similar to Leishmania, exist as one major developmental form
in an insect vector and another in the mammalian host (26). In contrast
to Leishmania, however, both of these forms are
extracellular. In the tsetse fly midgut, African trypanosomes are
present as an extracellular procyclic form, whereas in the bloodstream
of their mammalian hosts, they exist as a free-swimming bloodstream form. Bloodstream trypanosomes evade their hosts' immune response by
periodically switching their variant surface glycoprotein (VSG), a
phenomenon called antigenic variation that has also been the subject of
extensive investigation and many reviews (27-30).
While comparing the efficiency of sequencing random genomic DNA
fragments versus random cDNAs for discovering new genes
in African trypanosomes, we identified a random genomic fragment, i.e. a genomic survey sequence (GSS), encoding a protein
with similarity to GP63s of Leishmania and
Crithidia (31). Two random trypanosome cDNAs, or
expressed sequence tags (ESTs), have also now been found to encode
GP63-like proteins.2 Thus, we
undertook a characterization of the genes encoding these African
trypanosome homologues of GP63. We found that the African trypanosome
GP63 genes are predominantly expressed in the bloodstream form, leading
us to hypothesize that the presence of GP63 protects bloodstream
trypanosomes against complement-mediated lysis.
EXPERIMENTAL PROCEDURES
Trypanosomes
All experiments were conducted with material
isolated from the MVAT4 bloodstream clone of the Trypanosoma
brucei rhodesiense WRATat serodeme, or from procyclic organisms
derived from an MVAT5 bloodstream clone of the same serodeme (32, 33).
These bloodstream and procyclic organisms were maintained in rats or
grown in culture, respectively, as described previously (32-34).
Analysis of Nascent (Run-on) RNA in Isolated Nuclei
The
nuclei of bloodstream or procyclic trypanosomes were isolated using a
protocol kindly provided by Dr. Etienne Pays (Universite Libre de
Bruxelles) and described previously (35-37). They were incubated with
[ -32P] UTP, and their RNAs were isolated for use as
probes in Southern blots as described (35). In some experiments,
-amanitin (500 µg/ml) was added to the nuclei before
incubation.
Other Procedures
Total RNA and DNA were isolated from
bloodstream and/or procyclic trypanosomes as described (38, 39).
Southern and Northern blots were conducted as described (35).
Radioactive signals were quantitated by electronic autoradiography
using a Packard instant imager (Packard, Meriden, CT). A bacteriophage
ZAP library of cDNAs, and a bacteriophage FIX library of
genomic DNA fragments, both derived from T. brucei
rhodesiense bloodstream clone MVAT4 (32), were screened with an
African trypanosome GSS (31) using conventional procedures (40). The
cDNA inserts were rescued in the plasmid pBluescript.
BamHI fragments from a genomic DNA insert of a FIX clone
were subcloned into the same plasmid. DNA sequencing was conducted on
an Applied Biosystems model 373A stretch fluorescent automated DNA
sequencer (Perkin-Elmer). Known sequences were used to synthesize new
oligonucleotides for further sequencing. The sequences were analyzed
using the HIBIO MacIntosh DNASIS program (Hitachi) and the CLUSTAL
algorithm (41).
RESULTS
Identification of T. brucei cDNAs Encoding Homologues of
Leishmania and Crithidia GP63s
The African trypanosome GSS
possessing similarity to GP63 genes (31) was used as a probe to screen
cDNA and genomic DNA libraries derived from T. brucei
rhodesiense bloodstream clone MVAT4 (32). Positive clones were
identified in both libraries, and several clones from each were
selected for further characterization. Preliminary analyses of the
cDNA clones revealed two that contain a complete coding region.
Panel A of Fig. 1 depicts one
of these cDNAs and the relative locations of the 5 ends of the GSS
and ESTs containing the sequence similarities. The complete sequences of the two cDNAs were determined and found to be identical except for a small difference in the locations of their 5 ends within the
5 -untranslated region (UTR). Neither cDNA contains a 5 spliced leader, but both have an upstream termination codon in frame with the
first methionine codon.
Fig. 1.
Demonstration of the presence of GP63 genes
in African trypanosomes. Panel A, diagrams of a cDNA
(GenBank accession number U86345), two ESTs (accession numbers W68902
and AA023839), and one GSS (accession number B07363) derived from
T. brucei GP63 genes. The large box in the
cDNA diagram indicates the coding region, and the small
boxes show the 5 - and 3 -untranslated regions. Panel
B, diagram of three adjacent T. brucei GP63 genes in a
14-kb DNA insert from a bacteriophage clone of T. brucei
genomic DNA. The segment shown in black is a 6.0-kb genomic
DNA region whose complete sequence was determined (accession number
U86346). The indicated restriction sites are for BamHI
(B), PstI (P), BglII (L), and EcoRV (R). Panel
C, Southern blot of T. brucei genomic DNA (3 µg/lane)
digested with EcoRI (E) and other restriction enzymes whose cleavage sites are indicated in panel B.
Arrows indicate BamHI fragments of 4.5 and 1.2 kb
derived from the region shown in panel B.
[View Larger Version of this Image (30K GIF file)]
The protein encoded by this cDNA sequence is compared with the
C. fasciculata GP63 sequence (24) and a GP63 sequence from Leishmania guyanensis (42) in Fig.
2. All of the published
Leishmania GP63 sequences from several different
Leishmania species display significant homology to the
African trypanosome sequence in a BLASTX search (data not shown) (43),
but the L. guyanensis GP63 shown in Fig. 2 has slightly more
homology than the others. The shaded boxes show positions in
the trypanosome sequence at which an identical amino acid occurs in the
Crithidia and/or Leishmania sequence. Across the
full 622-amino acid trypanosome sequence, 38% of the residues
(235/622) are identical to the Crithidia and/or Leishmania GP63s. Between positions 114 and 425, i.e. within the middle one-half of the trypanosome protein,
50% of the positions (156/313) are identical to the
Crithidia and/or Leishmania GP63s. Furthermore,
the positions of 19 cysteine residues (black ovals) and 10 proline residues (black triangles) are conserved in all three sequences. Because cysteines are involved in potential disulfide linkages and prolines disrupt secondary structure, the conservation of
these amino acid positions suggests that the three proteins have a
similar overall tertiary structure.
Fig. 2.
Comparison of the amino acid sequences of
GP63s from T. brucei GP63 gene 1 (Tbr GP63-1),
C. fasciculata (Cf GP63) (24), and L. guyanensis (Lg GP63) (42). Amino acid positions
in T. brucei GP63 gene 1 that are identical to corresponding
positions in either C. fasciculata GP63 and/or L. guyanensis GP63 are indicated by shaded boxes. The
positions of 19 cysteine and 10 proline residues conserved in all three
GP63s are denoted by black ovals and black triangles, respectively. The protease zinc-binding/catalytic site of Leishmania GP63s is indicated by the letters
Zn and the large open box encompassing all three
sequences. The putative macrophage binding site of SRYD in
Leishmania GP63s (11) is indicated by the small open
box. Potential glycosylation sites in T. brucei GP63
gene 1 are encircled by ovals. A highly acidic, serine-rich region near the C terminus of T. brucei GP63 gene 1 is
indicated by the overline bar.
[View Larger Version of this Image (73K GIF file)]
In the trypanosome protein, the longest stretch of amino acid identity
with the Crithidia and/or Leishmania GP63s occurs
at the 9 residues between positions 225-233, i.e.
HEIAHALGF, a region known to be at the catalytic site of the
zinc-protease activity of Leishmania GP63 (large open
box in Fig. 2). This region contains 2 histidines and 1 glutamic
acid that are conserved among all three sequences and have been shown
to be essential for the protease activity (44). Downstream of this
protease site are several other 4- and 5-amino acid segments in the
trypanosome protein that occur in the Crithidia and/or
Leishmania GP63s. Less well conserved in the trypanosome
protein is a sequence thought to be involved in macrophage binding,
i.e. SRYD at positions 250-253 in the Leishmania
sequence shown in Fig. 2 (11). Because African trypanosomes are not
known to interact directly with macrophages, it is not surprising that
this sequence is not conserved.
In general, the Crithidia and Leishmania GP63s
are more similar to each other than either is to the trypanosome
sequence, an observation expected from the fact that in phylogenetic
trees deduced from sequences of cytochrome c or
mitochondrial DNA, African trypanosomes are the most divergent of the
three organisms (45, 46). The least similarity of the trypanosome
protein with the Crithidia and/or Leishmania
GP63s occurs in the first 50 and last 50 residues of the trypanosome
sequence. However, near their N and C termini, all three proteins are
notably hydrophobic. The first 50 residues of the trypanosome protein
possess the hallmarks of a prepropeptide, as do the
Crithidia and Leishmania GP63s. The potential
N-terminal signal (pre)peptide in the trypanosome protein has a
positively charged arginine at position 8, followed by a number of
hydrophobic residues before the next charged residue, an aspartic acid
at position 22. The potential propeptide segment of the trypanosome
protein contains an Arg-Cys dipeptide thought to complex with zinc in
the catalytic site of the latent form of Leishmania major
GP63 (7, 47).
At its C terminus, the trypanosome protein terminates with a
hydrophobic tail whose sequence is consistent with the possibility that
this tail is replaced with a GPI anchor similar to most GP63s of
Crithidia and Leishmania (48). Immediately
upstream of this hydrophobic tail is a very acidic, serine-rich region
(overline in Fig. 2) that is less prominent in the
corresponding Crithidia and Leishmania proteins
shown in Fig. 2. However, other Leishmania GP63s not shown
have similar acidic, serine-rich regions in the same location,
suggesting that this motif may play a role in the functions of some,
but not all, GP63 variants.
Thus, the variety of amino acid similarities of this African
trypanosome protein with Leishmania and Crithidia
GP63s indicates that it shares structural properties, and likely
protease activity, with these other GP63s. On the basis of these amino
acid similarities, and for the purpose of brevity, we will henceforth
refer to this African trypanosome protein as GP63.
Characterization of Genes in T. brucei Encoding
GP63
Preliminary characterizations of several T. brucei genomic DNA clones that hybridized to the GSS indicated
that all but one contained either one or two GP63 genes. However, one
clone with a 14-kb insert was found to contain three adjacent GP63
genes and was chosen for further characterization (Fig. 1, panel
B). BamHI fragments of 4.5 and 1.2 kb were subcloned
from this insert and their complete sequences determined. The phage DNA
itself was used as a template for PCR amplifications and further
sequence determinations to verify that the 4.5-kb fragment is followed by the 1.2-kb fragment and to determine another 0.3 kb of downstream sequence. This 6.0 kb of sequence is denoted by the black
region in panel B. The 6.0-kb sequence, along with
additional Southern blots not shown, confirms the presence of three
adjacent GP63 genes in this region and demonstrates that they do not
share an identical sequence with each other or with the cDNA. Thus,
the genome of this T. brucei clone contains a minimum of
four GP63 genes, i.e. genes 1-4 indicated in Fig. 1 in
which gene 1 gave rise to the cDNA sequence. The three genes in the
cloned genomic DNA segment shown in Fig. 1B are separated by
intergenic regions of 124 and 1335 bp if the 5 - and 3 -UTRs of genes 2 and 3 are assumed to be about the same length as that of gene 1 (whose
UTR lengths are known from the cDNA sequence). A sequence very
similar to the 124-bp intergenic region occurs at the 3 end of the
1335-bp intergenic region (results not shown), suggesting that this
region might be the minimum segment necessary for precursor RNA
processing events if the three genes are transcribed into a
polycistronic precursor RNA, as are most tandemly repeated genes in
Trypanosomatids (49).
Panel C of Fig. 1 shows a Southern blot of trypanosome
genomic DNA digested with several restriction enzymes and probed with the GP63 cDNA shown in panel A. This probe hybridizes to
seven BamHI fragments, four of which are derived from the
genomic region shown in panel B, i.e., the 4.5- and 1.2-kb fragments (arrows in panel C) and two
flanking BamHI fragments of unknown length. One of the
additional BamHI fragments must contain GP63 gene 1 (whose
cDNA does not have an internal BamHI site). The other
two BamHI fragments likely contain at least one more GP63
gene, but no attempt was made to determine unambiguously the exact
number of GP63 genes per haploid genome. All of these genes are likely clustered on one or two chromosomes inasmuch as they appear to be
confined to two large EcoRI fragments (lane E of
panel C). The multiple number of BglII,
EcoRV, and PstI fragments hybridizing to the
cDNA probe is consistent with the many polymorphisms observed in
the four GP63 genes for which complete or partial sequence was
obtained.
Fig. 3 shows a comparison of the GP63s
encoded by gene 1 (as deduced from the cDNA) and gene 3, the two
trypanosome GP63 genes for which the complete coding sequence was
determined. Amino acid substitutions, and occasional small
deletions/additions, are scattered throughout most of the alignment.
The largest difference occurs just before the C-terminal hydrophobic
tails, where GP63-1, but not GP63-3, contains the highly acidic,
serine-rich region (overline in Fig. 3) mentioned above.
This region in GP63-3 contains some serines, but it is neither as long
nor as acidic as in GP63-1, and it actually resembles the corresponding
region in Crithidia GP63 (Fig. 2) more than GP63-1. The
putative protease zinc-binding/catalytic site (open box) is
the same in GP63-1 and -3. In contrast to the scattered amino acid
replacements between these two T. brucei GP63s, the amino
acid differences among the multiple GP63s of Leishmania
chagasi are confined to four or five specific regions (50). The
significance of this different distribution in amino acid changes among
the GP63s of these two organisms is not known, but it could reflect
differing functions of GP63s in the different organisms.
Fig. 3.
Comparison of the amino acid sequences of
GP63s encoded by GP63 genes 1 and 3 (GP63-1 and GP63-3) of T. brucei. Dots indicate positions of identity. The
open box labeled Zn corresponds to the active
protease site of Leishmania GP63s, and the
overline indicates the same highly acidic, serine-rich
region of GP63-1 shown in Fig. 2. Dashes are gaps introduced
to maximize alignment.
[View Larger Version of this Image (24K GIF file)]
Steady State GP63 mRNA Levels in T. brucei
Fig.
4 shows Northern blots of RNAs from
bloodstream and procyclic trypanosomes probed with the trypanosome GP63
cDNA and, as control hybridizations, with cDNAs encoding the
expressed VSG, procyclin, and tubulin. The GP63 cDNA hybridizes
strongly to a 3-kb RNA in bloodstream trypanosomes and only weakly to
the same sized RNA in procyclic trypanosomes. The 3-kb size is
consistent with the 2786 nucleotides in the GP63-1 cDNA and with
the sizes of GP63 mRNAs in Lieshmania and
Crithidia (24, 51). As expected, the VSG and procyclin
cDNAs hybridize predominantly to the bloodstream and procyclic
RNAs, respectively, and the tubulin cDNA hybridizes about equally
to both RNAs, indicating similar amounts of RNA were added to each
lane. The ratio of the GP63 signals in the bloodstream
versus procyclic RNA lanes was determined by electronic autoradiography to be at about 50:1. The ratio of the GP63 and VSG
signals in bloodstream RNA was not determined because the two
radioactive 32P-probes may have had differing specific
activities. However, in a duplicate screening of the T. brucei bloodstream MVAT4 cDNA library, about 1 GP63 cDNA
clone was detected for every 150 VSG cDNA clones. Thus, if the
ratio of the two cDNA species in this amplified cDNA library
reflects the levels of their corresponding mRNAs, the ratio of GP63
mRNA to VSG mRNA in bloodstream trypanosomes is about 1:150.
Although this ratio of mRNA levels cannot be extrapolated to an
estimate of the number of GP63 proteins in bloodstream trypanosomes, it
may still be worth noting that 1/150th of the 107 VSGs on
the surface of a bloodstream trypanosome (52) is 67,000, or about
one-sixth the maximum of 500,000 GP63 molecules on the surface of
infective promastigotes of some Leishmania species (7).
Fig. 4.
Northern blots of total RNA (5 µg/lane)
from bloodstream (B) or procyclic (P)
trypanosomes. The RNAs were probed with cDNAs encoding GP63
(panel A), MVAT4 VSG (panel B), procyclin (panel C) and tubulin (panel D).
[View Larger Version of this Image (74K GIF file)]
Transcription of the GP63 Genes in T. brucei
Nuclear run-on
transcription experiments have been used to demonstrate that the active
telomere-linked VSG gene is transcribed in bloodstream trypanosomes,
but not in procyclic trypanosomes (29, 32). In contrast, many tandemly
repeated genes in Trypanosomatids, including GP63 genes in
Leishmania, are transcribed at all stages of the organisms'
life cycles, and their steady state mRNA levels are determined by
post-transcriptional regulatory events (reviewed in Refs. 29 and 53).
To determine whether the bloodstream expression of the GP63 genes in
African trypanosomes is regulated at the level of transcription
(similar to VSG genes) or at a post-transcriptional step (similar to
most other Trypanosomatid genes), we conducted similar nuclear run-on
experiments. Radiolabeled run-on RNAs from nuclei of procyclic and
bloodstream trypanosomes were used to probe the GP63 cDNA.
Panel B of Fig. 5 shows the
results when procyclic run-on RNA was used as the probe. As expected,
procyclic RNA hybridizes to the procyclin and tubulin genes but not to
the VSG gene. It also hybridizes with a strong signal to GP63 gene 1. Thus, GP63 RNA is synthesized in procyclic organisms, even though they
contain very little mature GP63 mRNA detectable on Northern blots.
Panels C and D of Fig. 5 show a similar
experiment using run-on RNA from bloodstream MVAT4 nuclei in absence or
presence of -amanitin. Transcription from the VSG and procyclin gene
expression sites is known to be resistant to -amanitin, suggesting
that these expression sites are transcribed by RNA polymerase I or a
modified RNA polymerase II (54, 55). In the absence of -amanitin (panel C), nascent RNA from bloodstream nuclei hybridizes
strongly to the MVAT4 VSG gene and more weakly to the tubulin and GP63 genes. Thus, the single MVAT4 VSG gene is transcribed at a much higher
rate than are the multiple GP63s, consistent with the 1:150 ratio of
their respective cDNAs in the MVAT 4 cDNA library. The trace-level hybridization to the procyclin gene observed here has been
reported previously (56, 57). When -amanitin was present during the
bloodstream nuclei incubation (panel D), transcription of
the VSG and procyclin genes was unaffected, but transcription of the
genes for tubulin and GP63 was nearly abolished, indicating that the
GP63 genes are transcribed by a conventional RNA polymerase II, similar
to the tubulin genes, but distinct from VSG and procyclin genes.
Although a weaker signal is obtained to the GP63 gene in bloodstream
versus procyclic forms, electronic autoradiography revealed
that the ratio of the GP63 and tubulin transcripts remains constant
(results not shown), indicating that the levels of transcription of
GP63 are the same in both developmental stages and that the differential steady state mRNA levels observed are due to
post-transcriptional regulatory events.
Fig. 5.
Analysis of nascent GP63 transcripts in
procyclic and bloodstream form trypanosomes. Run-on RNA prepared
from nuclei of procyclic and bloodstream trypanosomes incubated in the
absence ( ) and presence (+) of -amanitin was used to probe
Southern blots. Panel A shows a photograph of an ethidium
bromide-stained gel containing the excised inserts of different
plasmids (1-2 µg/lane). Fragment V encodes the MVAT4 VSG;
fragment P encodes procyclin; fragment T encodes
- and -tubulin; fragment G encodes GP63. The slowest
migrating fragments in lanes 1-3 are linearized vectors.
The 0.2-, 1.3-, and 1.5-kb fragments in lane 4 are vector fragments digested away from the insert. Panels B-D are
autoradiograms of blots containing the fragments shown in panel
A.
[View Larger Version of this Image (45K GIF file)]
DISCUSSION
Despite the numerous studies devoted to Leishmania
GP63s since their discovery, the potential functions of this family of surface proteases and the identities of their substrates in
vivo remain subjects of speculation (7, 8). The identification of
an expressed GP63-like gene in C. fasciculata (24), a
trypanosomatid whose life cycle is confined to insects, suggests that
one of the main roles of GP63 for Leishmania occurs during
the parasite's insect stages. Supporting this possibility is the
finding that another protozoan parasite of insects, Herpetomonas
samuelpessoai, also has a GP63-like metalloprotease activity on
its surface (58, 59). However, several other studies suggest that GP63
is crucial for the intracellular existence of Leishmania in
its mammalian host. These investigations indicate that GP63
participates in the attachment and entry of Leishmania into
host macrophages and contributes to its survival within the macrophage
(reviewed in Refs. 7, 8, and 44). All Leishmania species
examined have at least six tandem copies of closely related genes
encoding slightly different GP63 proteins, and some species have more
than 20 tandem GP63 genes (7, 42, 60). The simplest interpretation of all these biochemical and molecular biology studies may be that the
multiple GP63s serve a variety of functions throughout the Leishmania life cycle.
The identification of GP63-like genes in African trypanosomes leads to
a further consideration of the potential functions of GP63, inasmuch as
African trypanosomes are not known to interact with macrophages or to
have a natural intracellular stage during the life cycle involving
humans and the tsetse fly. Likewise, the expression of GP63
predominantly in bloodstream trypanosomes is counter to what one might
expect, based on the detection of GP63s on the surface of the
insect-specific protozoa, C. fasciculata and H. samuelpessoai. It is worth mentioning, however, that in experimental infections of rats and mice with Trypanosoma brucei brucei, intracellular parasites have been reported to occur in the
epithelium (ependymal cells) that covers the choroid plexus and
constitutes the local blood-brain barrier (61-63). Although, to our
knowledge, the existence of an intracellular form of African trypanosomes has not been reconfirmed since the original reports in
1982-1986, this observation might be of significance in considering a
potential role for GP63 when the parasite crosses the blood-brain barrier.
The nuclear run-on assays (Fig. 5) indicated that the GP63 genes are
transcribed in both procyclic and bloodstream trypanosomes by an
-amanitin-sensitive RNA polymerase, in contrast to the expressed VSG
gene, which is transcribed exclusively in bloodstream forms by an
-amanitin-resistant polymerase. However, Northern blots showed that
the GP63 mRNAs accumulate to a detectable steady-state level only
in bloodstream trypanosomes, as do VSG mRNAs. In the case of VSG
mRNAs, their semiconserved 3 -UTRs are important in conferring the
bloodstream stage specificity to the VSG mRNAs (64). A multiple
alignment of the three 3 -UTRs of the sequenced trypanosome GP63 genes
revealed a high level of homology in those regions. Our attempts to
identify substantive sequence similarities in the 3 -UTR sequences of
several expressed VSG genes and these three GP63 3 -UTRs were not
particularly revealing; however, a sequence resemblance to a 14-mer
element conserved in all VSG mRNAs was observed immediately
upstream of the polyadenylation site of the GP63 genes. The presence of
this 14-mer element has been shown to be necessary, but not sufficient,
for VSG gene regulation (64).
Many questions remain about the location and differential expression of
GP63s in African trypanosomes, and the results described here provide
the basis from which to deduce their possible functions. The sequence
conservation of the region known to be at the catalytic site of the
zinc-protease activity and the complete conservation of 19 cysteines
and 10 prolines (see Fig. 2) suggest that the GP63 protease activity
does indeed contribute to the survival of the bloodstream stage of
African trypanosomes. Although we have not yet shown that this
trypanosome protein is a membrane-bound, proteolytically active,
homologue of Leishmania GP63, we anticipate that a
demonstration of zinc-protease activity in the native or recombinant
protein will be forthcoming. An attractive possible function for GP63
in African trypanosomes is to mediate their known resistance to
complement-mediated lysis. Devine et al. (65) showed that,
whereas bloodstream trypanosomes activate the alternative pathway of
complement in human serum, they are not lysed because the complement
cascade does not go beyond establishment of C3 convertase on the
parasite surface. In their study, the trypanosomes displayed high
levels of C3 deposition as well as factor B on their surface. Similar
results demonstrating interrupted complement fixation on
Leishmania promastigotes expressing high levels of GP63 were
reported recently (18). A test of the complement resistance model in
African trypanosomes will be to overexpress GP63 in bloodstream trypanosomes to see whether their resistance to complement-mediated lysis is increased, and to see whether procyclic trypanosomes engineered to express GP63 acquire resistance (procyclic T. brucei is susceptible to complement-mediated cytolysis; Ref.
66).
Finally, the amount of GP63 on the surface of several
Leishmania species has been shown to increase as much as
11-fold when promastigotes develop in culture from logarithmic forms to
a stationary infective "metacyclic" form (51, 67). Thus, it is
tempting to speculate that GP63 is also highly expressed in metacyclic African trypanosomes, the infective form of the parasite that first
comes in contact with the immune system. Consistent with this
possibility is a preliminary report of a 65-kDa membrane-bound metalloprotease in infective metacyclic trypomastigotes of
Trypanosoma cruzi (68), an intracellular parasite that
causes Chagas disease in Latin America and must also evade
complement-mediated lysis before entering host cells.
FOOTNOTES
*
This work was supported in part by National Institutes of
Health Grant AI32135.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) U86345 (cDNA) and U86346
(genomic fragment).
To whom correspondence should be addressed: Dept. of Biochemistry,
University of Iowa, Iowa City, IA 52242. Tel: 319-335-7889; Fax:
319-335-6764.
1
The abbreviations used are: GP63, glycoprotein
63; VSG, variant surface glycoprotein; GSS, genome survey sequence; kb,
kilobase(s); bp, base pair(s); EST, expressed sequence tag; UTR,
untranslated region.
2
P. Majiwa, personal communication.
ACKNOWLEDGEMENTS
We thank Loren Donelson, Wafaa Takash, and
Rodney Morgan for assistance in library screening and sequencing
experiments, Mehrdad Pedram for providing procyclic nuclei, Drs. Jay
Bangs and Andrew Brittingham for helpful advice and suggestions, and
the University of Iowa DNA facility for automated DNA sequence
determinations.
REFERENCES
-
Pearson, R. D., Wheeler, D. A., Harrison, L. H., and Kay, H. D.
(1983)
Rev. Infect. Dis.
5,
907-926
[Medline]
[Order article via Infotrieve]
-
Etges, R., Bouvier, J., and Bordier, C.
(1986)
EMBO J.
5,
597-601
[Medline]
[Order article via Infotrieve]
-
Fong, D., and Chang, K.-P.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
7366-7370
[Abstract/Free Full Text]
-
Lepay, D. A., Nogueria, N., and Cohn, Z.
(1983)
J. Exp. Med.
157,
1562-1572
[Abstract/Free Full Text]
-
Bordier, C.
(1987)
Parasitol. Today
3,
151-153
[CrossRef][Medline]
[Order article via Infotrieve]
-
Chang, K.-P., and Chaudhuri, G.
(1990)
Annu. Rev. Microbiol.
44,
499-529
[CrossRef][Medline]
[Order article via Infotrieve]
-
Medina-Acosta, E., Beverley, S. M., and Russell, D. G.
(1993)
Infect. Agents Dis.
2,
25-34
[Medline]
[Order article via Infotrieve]
-
Bouvier, J., Schneider, P., and Etges, R.
(1995)
Methods Enzymol.
248,
614-633
[Medline]
[Order article via Infotrieve]
-
Englund, P. T.
(1993)
Annu. Rev. Biochem.
62,
121-138
[CrossRef][Medline]
[Order article via Infotrieve]
-
Chang, C.-S., and Chang, K.-P.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
100-104
[Abstract/Free Full Text]
-
Soteriadou, K. P., Remoundos, M. S., Katsikas, M. D., Tzinia, A. K., Tsikaris, V., Sakarellos, D., and Tzartos, S. J.
(1992)
J. Biol. Chem.
267,
13980-13985
[Abstract/Free Full Text]
-
Liu, X., and Chang, K.-P.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
4991-4995
[Abstract/Free Full Text]
-
Emini, E. A., Jameson, B. A., and Wimmer, E.
(1983)
Nature
304,
699-703
[CrossRef][Medline]
[Order article via Infotrieve]
-
Carvalho, E. B., Vaz, M. G. M., Rezende, J. M., and Rassi, A.
(1977)
Rev. Goiana Med.
23,
41-45
-
Chaudhuri, G., Chaudhuri, M., Pan, A., and Chang, K.-P.
(1989)
J. Biol. Chem.
264,
7483-7489
[Abstract/Free Full Text]
-
McGwire, B., and Chang, K.-P.
(1994)
Mol. Biochem. Parasitol.
66,
345-347
[CrossRef][Medline]
[Order article via Infotrieve]
-
Puentes, S. M., Dwyer, D. M., Bates, P. A., and Joiner, K. A.
(1989)
J. Immunol.
143,
3743-3749
[Abstract]
-
Brittingham, A., Morrison, C. J., McMaster, W. R., McGwire, B. S., Chang, K.-P., and Mosser, D. M.
(1995)
J. Immunol.
155,
3102-3111
[Abstract]
-
Olobo, J. O., Anjili, C. O., Gicheru, M. M., Mbati, P. A., Kariuki, T. M., Githure, J. I., Koech, D. K., and McMaster, W. R.
(1995)
Vet. Parasitol.
60,
199-212
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gheorghiu, M., Dellagi, K., and Gicquel, B.
(1995)
Microbiology
141,
1585-1592
[Abstract/Free Full Text]
-
Xu, D., McSorley, S. J., Chatfield, S. N., Dougan, G., and Liew, F. Y.
(1995)
Immunology
85,
1-7
[Medline]
[Order article via Infotrieve]
-
Connell, N. D., Medina-Acosta, E., McMaster, W. R., Bloom, B., and Russell, D. G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
11473-11477
[Abstract/Free Full Text]
-
Yang, D. M., Fairweather, N., Button, L. L., McMaster, W. R., Kahl, L. P., and Liew, F. Y.
(1990)
J. Immunol.
145,
2281-2285
[Abstract]
-
Inverso, J. A., Medina-Acosta, E., O'Connor, J., Russell, D. G., and Cross, G. A. M.
(1993)
Mol. Biochem. Parasitol.
57,
47-54
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wallace, F. G.
(1966)
Parasitol. Rev.
18,
124-193
-
Vickerman, K., Tetley, L., Hendry, K. A., and Turner, C. M.
(1988)
Biol. Cell
64,
109-119
[CrossRef][Medline]
[Order article via Infotrieve]
-
Cross, G. A. M.
(1990)
Annu. Rev. Immunol.
8,
93-110
-
Borst, P., and Rudenko, G.
(1994)
Science
264,
1872-1873
[Free Full Text]
-
Vanhamme, L., and Pays, E.
(1995)
Microbiol. Rev.
59,
223-240
[Abstract/Free Full Text]
-
Donelson, J. E.
(1995)
J. Biol. Chem.
270,
7783-7786
[Free Full Text]
-
El-Sayed, N. M. A., and Donelson, J. E.
(1997)
Mol. Biochem. Parasitol.
84,
167-178
[CrossRef][Medline]
[Order article via Infotrieve]
-
Alarcon, C. M., Son, H. J., Hall, T., and Donelson, J. E.
(1994)
Mol. Cell. Biol.
14,
5579-5591
[Abstract/Free Full Text]
-
Lu, Y., Alarcon, C. M., Hall, T., Reddy, L. V., and Donelson, J. E.
(1994)
Mol. Cell. Biol.
14,
3971-3980
[Abstract/Free Full Text]
-
Lu, Y., Hall, T., Gay, L. S., and Donelson, J. E.
(1993)
Cell
72,
397-406
[CrossRef][Medline]
[Order article via Infotrieve]
-
Morgan, R. W., El-Sayed, N. M. A., Kepa, J. K., Pedram, M., and Donelson, J. E.
(1996)
J. Biol. Chem.
271,
9771-9777
[Abstract/Free Full Text]
-
Coquelet, H., Tebabi, P., Pays, A., Steinert, M., and Pays, E.
(1989)
Mol. Cell Biol.
9,
4022-4025
[Abstract/Free Full Text]
-
Coquelet, H., Steinert, M., and Pays, E.
(1991)
Mol. Biochem. Parasitol.
44,
33-42
[CrossRef][Medline]
[Order article via Infotrieve]
-
Chirgwin, J. M., Przbyla, J. M., MacDonald, R. J., and Rutter, W. J.
(1979)
Biochemistry
18,
5294-5299
[CrossRef][Medline]
[Order article via Infotrieve]
-
Chomczynski, P., and Sacchi, N.
(1987)
Anal. Biochem.
162,
156-159
[Medline]
[Order article via Infotrieve]
-
Sambrook, J., Fritsch, E., and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Higgins, D. G., and Sharp, P. M.
(1988)
Gene (Amst.)
73,
237-244
[CrossRef][Medline]
[Order article via Infotrieve]
-
Steinkraus, H. B., Greer, J. M., Stephenson, D. C., and Langer, P. J.
(1993)
Mol. Biochem. Parasitol.
62,
173-186
[CrossRef][Medline]
[Order article via Infotrieve]
-
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410
[CrossRef][Medline]
[Order article via Infotrieve]
-
McGwire, B. S., and Chang, K.-P.
(1996)
J. Biol. Chem.
271,
7903-7909
[Abstract/Free Full Text]
-
Fernandes, A. P., Nelson, K., and Beverley, S. M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
11608-11612
[Abstract/Free Full Text]
-
Landweber, L. F., and Gilbert, W.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
918-921
[Abstract/Free Full Text]
-
Bouvier, J., Schneider, P., Etges, R., and Bordier, C.
(1990)
Biochemistry
29,
10113-10119
[CrossRef][Medline]
[Order article via Infotrieve]
-
Cross, G. A. M.
(1990)
Annu. Rev. Cell Biol.
6,
1-39
[CrossRef]
-
Ramamoorthy, R., Swihart, K. G., McCoy, J. J., Wilson, M. E., and Donelson, J. E.
(1995)
J. Biol. Chem.
270,
12133-12139
[Abstract/Free Full Text]
-
Roberts, S. C., Swihart, K. G., Agey, M. W., Ramamoorthy, R., Wilson, M. E., and Donelson, J. E.
(1993)
Mol. Biochem. Parasitol.
62,
157-172
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ramamoorthy, R., Donelson, J. E., Paetz, K. E., Maybodi, M., Roberts, S. C., and Wilson, M. E.
(1992)
J. Biol. Chem.
267,
1888-1895
[Abstract/Free Full Text]
-
Turner, M. J.
(1985)
Br. Med. Bull.
41,
137-143
[Abstract/Free Full Text]
-
Clayton, C.
(1992)
in
Progress in Nucleic Acid Research and Molecular Biology (Moldave, K., and Cohn, W., eds), pp. 37-66, Academic Press, San Diego
-
Rudenko, G., Chung, H.-M. M., Pham, V. P., and Van der Ploeg, L. H. T.
(1991)
EMBO J.
10,
3387-3397
[Medline]
[Order article via Infotrieve]
-
Zomerdijk, J. C. B. M., Kieft, R., and Borst, P.
(1991)
Nature
353,
772-775
[CrossRef][Medline]
[Order article via Infotrieve]
-
Pays, E., Coquelet, H., Tebabi, P., Pays, A., Jefferies, D., Steinert, M., Koenig, E., Williams, R. O., and Roditi, I.
(1990)
EMBO J.
9,
3145-3151
[Medline]
[Order article via Infotrieve]
-
Rudenko, G., Bishop, D., Gottesdiener, K., and Van der Ploeg, L. H. T.
(1989)
EMBO J.
8,
4259-4263
[Medline]
[Order article via Infotrieve]
-
Schneider, P., and Glaser, T. A.
(1993)
Mol. Biochem. Parasitol.
58,
277-282
[CrossRef][Medline]
[Order article via Infotrieve]
-
Etges, R.
(1992)
Acta Trop.
50,
205-217
[CrossRef][Medline]
[Order article via Infotrieve]
-
Szarfman, A., Luquetti, A., Rassi, A., Rezende, J. M., and Schmunis, G. A.
(1981)
Am. J. Trop. Med. Hyg.
30,
43-46
-
Abolarin, M. O., Evans, D. A., Tovey, D. G., and Ormerod, W. E.
(1982)
Br. Med. J.
285,
1380-1382
-
Ormerod, W. E., and Hussein, M. S.-A.
(1986)
Trans. R. Soc. Trop. Med. Hyg.
80,
626-633
[CrossRef][Medline]
[Order article via Infotrieve]
-
Abolarin, M. O., Stamford, S. A., and Ormerod, W. E.
(1986)
Trans. R. Soc. Trop. Med. Hyg.
80,
618-625
[CrossRef][Medline]
[Order article via Infotrieve]
-
Berberof, M., Vanhamme, L., Tebabi, P., Pays, A., Jefferies, D., Welburn, S., and Pays, E.
(1995)
EMBO J.
14,
2925-2934
[Medline]
[Order article via Infotrieve]
-
Devine, D. V., Falk, R. J., and Balber, A. E.
(1986)
Infect. Immun.
52,
223-229
[Abstract/Free Full Text]
-
Mosser, D. M., and Roberts, J. F.
(1982)
Exp. Parasitol.
54,
310-316
[CrossRef][Medline]
[Order article via Infotrieve]
-
Weider, M. K., Lemesre, J. L., Santoro, F., Kusnierz, J. P., Sadigursky, M., and Capron, A.
(1989)
Parasite Immunol.
11,
197-209
[Medline]
[Order article via Infotrieve]
-
Salles, J. M., Thomas, N., Carreira Fragoso, M. A., and
Goldenberg, S. (1996) Mem. Inst. Oswaldo Cruz. 91,
(suppl.), 269
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Kulkarni, C. L. Olson, D. M. Engman, and B. S. McGwire
Trypanosoma cruzi GP63 Proteins Undergo Stage-Specific Differential Posttranslational Modification and Are Important for Host Cell Infection
Infect. Immun.,
May 1, 2009;
77(5):
2193 - 2200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Antoine-Moussiaux, P. Buscher, and D. Desmecht
Host-Parasite Interactions in Trypanosomiasis: on the Way to an Antidisease Strategy
Infect. Immun.,
April 1, 2009;
77(4):
1276 - 1284.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Yao, J. E. Donelson, and M. E. Wilson
Internal and Surface-Localized Major Surface Proteases of Leishmania spp. and Their Differential Release from Promastigotes
Eukaryot. Cell,
October 1, 2007;
6(10):
1905 - 1912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-L. Chung, M. Carrington, and M. C. Field
Cytoplasmic Targeting Signals in Transmembrane Invariant Surface Glycoproteins of Trypanosomes
J. Biol. Chem.,
December 24, 2004;
279(52):
54887 - 54895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Cuevas, J. J. Cazzulo, and D. O. Sanchez
gp63 Homologues in Trypanosoma cruzi: Surface Antigens with Metalloprotease Activity and a Possible Role in Host Cell Infection
Infect. Immun.,
October 1, 2003;
71(10):
5739 - 5749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. LaCount, A. E. Gruszynski, P. M. Grandgenett, J. D. Bangs, and J. E. Donelson
Expression and Function of the Trypanosoma brucei Major Surface Protease (GP63) Genes
J. Biol. Chem.,
June 27, 2003;
278(27):
24658 - 24664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Gruszynski, A. DeMaster, N. M. Hooper, and J. D. Bangs
Surface Coat Remodeling during Differentiation of Trypanosoma brucei
J. Biol. Chem.,
June 27, 2003;
278(27):
24665 - 24672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. McGwire, W. A. O'Connell, K.-P. Chang, and D. M. Engman
Extracellular Release of the Glycosylphosphatidylinositol (GPI)-linked Leishmania Surface Metalloprotease, gp63, Is Independent of GPI Phospholipolysis. IMPLICATIONS FOR PARASITE VIRULENCE
J. Biol. Chem.,
March 8, 2002;
277(11):
8802 - 8809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. McConville, K. A. Mullin, S. C. Ilgoutz, and R. D. Teasdale
Secretory Pathway of Trypanosomatid Parasites
Microbiol. Mol. Biol. Rev.,
March 1, 2002;
66(1):
122 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Verdun, N. Di Paolo, T. P. Urmenyi, E. Rondinelli, A. C. C. Frasch, and D. O. Sanchez
Gene Discovery through Expressed Sequence Tag Sequencing in Trypanosoma cruzi
Infect. Immun.,
November 1, 1998;
66(11):
5393 - 5398.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|